RADIAN B MUSCLE LOTION 1.4%w/w,0. %v/v Cutaneous Solution

Country: Ireland

Language: English

Source: HPRA (Health Products Regulatory Authority)

Active ingredient:

MENTHOL CAMPHOR AMMONIUM SALICYLATE METHYL SALICYLATE

Available from:

William Ransom & Son Plc

INN (International Name):

MENTHOL CAMPHOR AMMONIUM SALICYLATE METHYL SALICYLATE

Dosage:

1.4%w/w,0. %v/v

Pharmaceutical form:

Cutaneous Solution

Prescription type:

Product not subject to medical prescription

Authorization status:

Withdrawn

Authorization date:

2008-01-22

Summary of Product characteristics

PART II
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE MEDICINAL PRODUCT
Radian B Muscle Lotion
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
For excipients, see 6.1.
3 PHARMACEUTICAL FORM
Cutaneous Solution
A straw-coloured clear liquid with characteristic odour.
4 CLINICAL PARTICULARS
4.1 THERAPEUTIC INDICATIONS
For symptomatic relief of rheumatic and muscular pain, fibrositis, sciatica, lumbago, sprained ligaments, bruises,
stiffness, strains, tennis elbow, golf shoulder and unbroken chilblains.
4.2 POSOLOGY AND METHOD OF ADMINISTRATION
Adults and Children over 12 years:
Sprinkle liberally onto the affected area and massage. Apply to the affected area 2 to 3 times a day.
4.3 CONTRAINDICATIONS
1.
Hypersensitivity to any of the ingredients.
2.
Use in pregnancy or lactation.
3.
Use in children under 12 years.
4.
This product should not be applied to irritated or broken skin. If irritation develops, use of the product should
be discontinued.
4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE
Hands should be thoroughly washed after use of this product and care should be exercised to avoid contact with the
eyes and mucous membranes.
If you are on other medication, consult your doctor before use.
If pain persists or redness develops, consult your doctor.
Active Constituents
% w/v
Levomenthol
1.40
Racemic camphor
0.60
Ammonium salicylate
1.00
Methyl salicylate
0.60
IRISH MEDICINES BOARD
________________________________________________________________________________________________________________________
_Date Printed 18/07/2006_
_CRN 2025615_
_page number: 1_
4.5 INTERACTION WITH OTHER MEDICINAL PRODUCTS AND OTHER FORMS OF INTERACTION
When used concurrently with oral anti-coagulants, the agent will necessitate a lowering of their dosage and a careful
monitoring of the coagulation system.
4.6 PREGNANCY AND LACTATION
There is